156 related articles for article (PubMed ID: 9032575)
1. Histopathological aspects of mucosal injury related to non-steroidal anti-inflammatory drugs.
Taha AS
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():12-5. PubMed ID: 9032575
[TBL] [Abstract][Full Text] [Related]
2. Acute NSAID-related transmural duodenitis and extensive duodenal ulceration.
Hashash JG; Atweh LA; Saliba T; Chakhachiro Z; Al-Kutoubi A; Tawil A; Barada KA
Clin Ther; 2007 Nov; 29(11):2448-52. PubMed ID: 18158085
[TBL] [Abstract][Full Text] [Related]
3. Clinical symptoms, endoscopic findings and histologic features of gastroduodenal non-steroidal anti-inflammatory drugs lesions.
Aabakken L
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S19-22. PubMed ID: 10379465
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
Russell RI
Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
[TBL] [Abstract][Full Text] [Related]
5. Duodenal histology, ulceration, and Helicobacter pylori in the presence or absence of non-steroidal anti-inflammatory drugs.
Taha AS; Dahill S; Nakshabendi I; Lee FD; Sturrock RD; Russell RI
Gut; 1993 Sep; 34(9):1162-6. PubMed ID: 8406146
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
Scarpignato C; Pelosini I
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
[TBL] [Abstract][Full Text] [Related]
7. Upper gastrointestinal lesions in elderly patients presenting for endoscopy: relevance of NSAID usage.
Bellary SV; Isaacs PE; Lee FI
Am J Gastroenterol; 1991 Aug; 86(8):961-4. PubMed ID: 1858761
[TBL] [Abstract][Full Text] [Related]
8. Infection with Helicobacter pylori and long-term use of non-steroidal antiinflammatory drugs.
Vcev A; Ivandić A; Vceva A; Stimac D; Takac B; Mikolasević I; Jovanović S; Dmitrović B; Vuković D; Egić B
Acta Med Croatica; 1998; 52(1):27-31. PubMed ID: 9599813
[TBL] [Abstract][Full Text] [Related]
9. [Non-steroidal anti-inflammatory agents in ulcerative diseases. Mucosal damage of the ventricle and duodenum].
Manniche C; Malchow-Møller A
Ugeskr Laeger; 1987 Aug; 149(32):2161-2. PubMed ID: 3450026
[No Abstract] [Full Text] [Related]
10. [Present position in the prevention and therapy of NSAID-induced ulcers].
Lehmann FS; Beglinger C
Schweiz Med Wochenschr; 1999 Jul; 129(29-30):1073-80. PubMed ID: 10464910
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori and benign upper digestive disease.
Lai LH; Sung JJ
Best Pract Res Clin Gastroenterol; 2007; 21(2):261-79. PubMed ID: 17382276
[TBL] [Abstract][Full Text] [Related]
12. A histological study of the effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the gastric and duodenal mucosa.
Moghal N; Jafarey NA
J Pak Med Assoc; 1989 Nov; 39(11):287-90. PubMed ID: 2516535
[TBL] [Abstract][Full Text] [Related]
13. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
[TBL] [Abstract][Full Text] [Related]
14. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
Koch M
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
[TBL] [Abstract][Full Text] [Related]
15. Gastric erosions induced by nonsteroidal anti-inflammatory drugs: clinical significance, pathogenesis, and therapeutic perspectives.
Agrawal NM; Aziz K
J Assoc Acad Minor Phys; 1995; 6(3):97-9. PubMed ID: 7663101
[TBL] [Abstract][Full Text] [Related]
16. Ulcers and gastritis.
Kashiwagi H
Endoscopy; 2003 Jan; 35(1):9-14. PubMed ID: 12510220
[TBL] [Abstract][Full Text] [Related]
17. [Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors].
Karateev AE; Nasonova VA
Ter Arkh; 2008; 80(5):62-6. PubMed ID: 18590118
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
[TBL] [Abstract][Full Text] [Related]
19. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors.
Laine L
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):25-32. PubMed ID: 12528071
[TBL] [Abstract][Full Text] [Related]
20. Can the diagnosis of NSAID-induced or Hp-associated gastric ulceration be predicted from histology?
Vieth M; Müller H; Stolte M
Z Gastroenterol; 2002 Sep; 40(9):783-8. PubMed ID: 12215946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
